Cargando…
Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow's Milk Allergic Mice
BACKGROUND: In previous studies, we showed that a fructo-oligosaccharide- (FOS-) supplemented diet enhanced oral immunotherapy (OIT) efficacy in a mouse model for cow's milk allergy. Fermentation of FOS by intestinal bacteria leads to production of short-chain fatty acids (SCFA) including butyr...
Autores principales: | Vonk, Marlotte M., Blokhuis, Bart R. J., Diks, Mara A. P., Wagenaar, Laura, Smit, Joost J., Pieters, Raymond H. H., Garssen, Johan, Knippels, Léon M. J., van Esch, Betty C. A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360042/ https://www.ncbi.nlm.nih.gov/pubmed/30800003 http://dx.doi.org/10.1155/2019/9062537 |
Ejemplares similares
-
Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
por: Vonk, Marlotte M., et al.
Publicado: (2017) -
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017) -
Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model
por: Wagenaar, Laura, et al.
Publicado: (2018) -
A network-based approach for identifying suitable biomarkers for oral immunotherapy of food allergy
por: van Bilsen, Jolanda H. M., et al.
Publicado: (2019) -
Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)